Morbidity and mortality in chronically transfused subjects with thalassemia and sickle cell disease: A report from the multi-center study of iron overload-Reference-Cited by-同舟云学术

Morbidity and mortality in chronically transfused subjects with thalassemia and sickle cell disease: A report from the multi-center study of iron overload

Published:2007 Issue:4 Volume:82 Page:255-265
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am. J. Hematol.

Author:

Fung Ellen B.,Harmatz Paul,Milet Meredith,Ballas Samir K.,De Castro Laura,Hagar Ward,Owen William,Olivieri Nancy,Smith-Whitley Kim,Darbari Deepika,Wang Winfred,Vichinsky Elliott,

Publisher

Wiley

Subject

Hematology

Reference32 articles.

1. SURVIVAL AND CAUSES OF DEATH IN THALASSAEMIA MAJOR

2. Prevention of a First Stroke by Transfusions in Children with Sickle Cell Anemia and Abnormal Results on Transcranial Doppler Ultrasonography

3. Indications for red cell transfusion in sickle cell disease

4. The Clinical Sequelae of Intravascular Hemolysis and Extracellular Plasma Hemoglobin

5. Lactate dehydrogenase as a biomarker of hemolysis-associated nitric oxide resistance, priapism, leg ulceration, pulmonary hypertension, and death in patients with sickle cell disease

Cited by 127 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluating the Concept of Oral Manifestation of Thalassemia Major and Its Dental Consideration: A Report on Two Cases and a Literature Review;Journal of South Asian Association of Pediatric Dentistry;2024-04-27

2. Mortality in adults with sickle cell disease: Results from the sickle cell disease implementation consortium (SCDIC) registry;American Journal of Hematology;2024-03-07

3. Bone Health Impairment in Patients with Hemoglobinopathies: From Biological Bases to New Possible Therapeutic Strategies;International Journal of Molecular Sciences;2024-03-01

4. Compare the Efficacy and Safety of Deferoxamine, Deferasirox, and Deferiprone in Patients With Sickle Cell Disease or Transfusion-Dependent Anemia: A Network Meta-Analysis of Randomized Control Trials;Cureus;2024-02-05

5. The evolving treatment landscape for children with sickle cell disease;The Lancet Child & Adolescent Health;2023-11